The literature using a mouse model of Dravet Syndrome found that the effects of low-dose Δ9-THC are enhanced when combined with a sub-anticonvulsant dose of CBD [58]. This evidence concerns the gene OPN1MW and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.